CareLit · DOI-Nachweis · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Regulatory requirements for clinical trial and marketing authorisation application for cell-based medicinal products
DOI 10.1007/s00103-009-0991-5
Bibliografische Angaben
Nachweis in CareLit
Autor:innenSalmikangas, P.; Flory, E.; Reinhardt, J.; Hinz, T.; Maciulaitis, R.
ZeitschriftBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Ausgabe11/2009
Jahrgang / SeitenJg. 52 · S. 24 bis 29
Kernaussage aus der Literatur
Abstract-Vorschau
The new era of regenerative medicine has led to rapid development of new innovative therapies especially for diseases and tissue/organ defects for which traditional therapies and medicinal products have not provided satisfactory outcome. Although the clinical use and developments of cell-based medicinal products (CBMPs) could be witnessed already for a decade, robust scientific and regulatory provisions for these pr…
Zitieren
Zitierempfehlung
Salmikangas, P.; Flory, E.; Reinhardt, J.; Hinz, T.; Maciulaitis, R (2009) Regulatory requirements for clinical trial and marketing authorisation application for cell-based medicinal products. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 52 (11), 24 bis 29. https://doi.org/10.1007/s00103-009-0991-5
Mit CareLit weiterarbeiten